<DOC>
	<DOCNO>NCT01247350</DOCNO>
	<brief_summary>To evaluate safety tolerability LY3009104 give orally single multiple dos Japanese healthy subject .</brief_summary>
	<brief_title>A Study LY3009104 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male female . Male subject : Agree use 2 form highly effective method birth control female partner childbearing potential specify duration . Female subject : Females must pregnant , breastfeed , risk become pregnant study participation . Female subject childbearing potential must test negative pregnancy screen agree use 2 form highly effective method birth control , remain abstinent specify duration . Up third generation Japanese , define subject 's biological grandparent exclusive Japanese decent bear Japan . Are body mass index ( BMI ) 18.0 30.0 kg/m^2 , inclusive screening . Are subject previously complete withdrawn study study investigate LY3009104 , receive study drug . Have history current cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , hematological , neurological disorder capable significantly alter absorption , metabolism , elimination drug ; constitute risk take study medication ; interfere interpretation data . Show evidence significant active neuropsychiatric disease . Have current recent history herpes zoster simplex last 90 day prior randomization , history herpes zoster , disseminate herpes zoster involve multiple dermatome , ocular involvement , include herpes zoster involve ophthalmic branch trigeminal nerve . Have history rheumatoid arthritis . History malignancy , exception cure basal cell squamous cell carcinoma skin . History stomach intestinal surgery , except appendectomy and/or cholecystectomy allow . Receipt blood product within 2 month prior study entry .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>